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 Figure Line A and B: Coronary angiogram of the right and left coronary artery (middle: maximal absolute coronary 
blood flow [Q], minimal absolute microvascular resistance [R] and fractional flow reserve [FFR] were measured by 
intracoronary thermodilution); the red line in the proximal RCA corresponds to the segment visualized by OCT; Line 
C: Optical coherence tomography in the right coronary artery (proximal segment: dashed line in B); Line D: Left: 
normal endomyocardial biopsy. Middle-right: histology of the antibody mediated rejection in 5/2018 (pAMR2), with 
pericapillary deposition of C4d (immunofluorescence staining in green) and mononuclear infiltrate filling a capillary 
vessel (cross-section). 
 
 This case illustrates humoral-rejection related cardiac graft vasculopathy (CAV) in a 44 years-old 
heart transplant recipient. In 3/2018 at 3 years posttransplant de novo anti-HLA class II donor-
specific antibodies (DSA: DQ2 + DQ7 >25’000 MFI) were detected. The coronary angiogram (CA) 
in 2016 had been unsuspicious (line A,B; left) but optical coherence tomography (OCT) had noted 
a pathologic intima:media thickness ratio of 2:1 (line C, left). The CA in 3/2018, however showed 
mild type C CAV lesions in the distal LAD and RCA (line A,B; middle); moreover, OCT marked 
intimal “opacity” (line C, middle, 2-6 o’clock) compatible with “layered fibrotic plaques” described 
elsewhere1. Absolute coronary flow and fractional flow reserve suggested a normal coronary 
microcirculation (line A,B; middle), therefore, only antiproliferative treatment was reinforced in 
view of the unsuspicious endomyocardial histology (line D, left) and absent signs of DSA mediated 
endothelitis (negative immunofluorescent C4d-staining). In 5/2018, a follow-up endomyocardial 
biopsy showed moderate antibody-mediated rejection2 (pAMR2 H+/I+: line D middle-right), 
successfully treated with corticosteroids, eculizumab, intravenous immunoglobulins, and 
rituximab on top of tacrolimus and mycophenolate. However, in 8/2018, the patient developed 
severe LV dysfunction without persistent histological signs for AMR, while the CA noted type C 
CAV lesions with occlusion of the distal LAD, LCx and the left marginal artery; the OCT showed 
persisting intimal opacity (line C, right, 6-1 o’clock) compatible with sustained DSA-related 
toxicity. This case illustrates that intimal opacity detected by OCT heralded progression of 
intraluminal CAV in this recipient with positive DSA. 
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